Repository logo
 
Publication

Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024

dc.contributor.authorMaurel, Marine
dc.contributor.authorHoward, Jennifer
dc.contributor.authorKissling, Esther
dc.contributor.authorPozo, Francisco
dc.contributor.authorPérez-Gimeno, Gloria
dc.contributor.authorBuda, Silke
dc.contributor.authorSève, Noémie
dc.contributor.authorMcKenna, Adele
dc.contributor.authorMeijer, Adam
dc.contributor.authorRodrigues, Ana Paula
dc.contributor.authorMartínez-Baz, Iván
dc.contributor.authorMlinarić, Ivan
dc.contributor.authorLatorre-Margalef, Neus
dc.contributor.authorTúri, Gergő
dc.contributor.authorLazăr, Mihaela
dc.contributor.authorMazagatos, Clara
dc.contributor.authorEcheverria, Aitziber
dc.contributor.authorAbela, Stephen
dc.contributor.authorBourgeois, Marc
dc.contributor.authorMachado, Ausenda
dc.contributor.authorDürrwald, Ralf
dc.contributor.authorPetrović, Goranka
dc.contributor.authorOroszi, Beatrix
dc.contributor.authorJancoriene, Ligita
dc.contributor.authorMarin, Alexandru
dc.contributor.authorHusa, Petr
dc.contributor.authorDuffy, Roisin
dc.contributor.authorDijkstra, Frederika
dc.contributor.authorGallardo García, Virtudes
dc.contributor.authorGoerlitz, Luise
dc.contributor.authorEnouf, Vincent
dc.contributor.authorBennett, Charlene
dc.contributor.authorHooiveld, Mariëtte
dc.contributor.authorGuiomar, Raquel
dc.contributor.authorTrobajo-Sanmartín, Camino
dc.contributor.authorVišekruna Vučina, Vesna
dc.contributor.authorSamuelsson Hagey, Tove
dc.contributor.authorLameiras Azevedo, Ana Sofía
dc.contributor.authorCastilla, Jesús
dc.contributor.authorXuereb, Gerd
dc.contributor.authorDelaere, Bénédicte
dc.contributor.authorGómez, Verónica
dc.contributor.authorTolksdorf, Kristin
dc.contributor.authorBacci, Sabrina
dc.contributor.authorNicolay, Nathalie
dc.contributor.authorKaczmarek, Marlena
dc.contributor.authorRose, Angela MC
dc.contributor.authorEuropean IVE group
dc.date.accessioned2025-03-07T13:34:13Z
dc.date.available2025-03-07T13:34:13Z
dc.date.issued2024-02-22
dc.description.abstractInfluenza A viruses circulated in Europe from September 2023 to January 2024, with influenza A(H1N1)pdm09 predominance. We provide interim 2023/24 influenza vaccine effectiveness (IVE) estimates from two European studies, covering 10 countries across primary care (EU-PC) and hospital (EU-H) settings. Interim IVE was higher against A(H1N1)pdm09 than A(H3N2): EU-PC influenza A(H1N1)pdm09 IVE was 53% (95% CI: 41 to 63) and 30% (95% CI: −3 to 54) against influenza A(H3N2). For EU-H, these were 44% (95% CI: 30 to 55) and 14% (95% CI: −32 to 43), respectively.pt_PT
dc.description.sponsorshipThe ‘Vaccine Effectiveness, Burden and Impact Studies’ (VEBIS) is a project of the European Centre for Disease Prevention and Control (ECDC) run under the framework contract No. ECDC/2021/019 (EU-PC) and ECDC/2021/016 (EU-H).pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationEuro Surveill. 2024 Feb;29(8):2400089. doi: 10.2807/1560-7917.ES.2024.29.8.2400089
dc.identifier.doi10.2807/1560-7917.ES.2024.29.8.2400089pt_PT
dc.identifier.issn1560-7917
dc.identifier.pmid38390651
dc.identifier.urihttp://hdl.handle.net/10400.18/10422
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherEuropean Centre for Disease Prevention and Control
dc.relation.hasversionhttps://openpolicyfinder.jisc.ac.uk/id/publication/30134
dc.relation.publisherversionhttps://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2024.29.8.2400089pt_PT
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt_PT
dc.subjectInfluenzapt_PT
dc.subjectVaccine Effectivenesspt_PT
dc.subjectVEBISpt_PT
dc.subjectPrimary Carept_PT
dc.subjectHospitalpt_PT
dc.subjectEurope
dc.subjectInvestigação em Serviços de Saúdept_PT
dc.subjectEstados de Saúde e de Doençapt_PT
dc.subjectInfecções Respiratórias
dc.subjectCuidados de Saúde
dc.titleInterim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024pt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.issue8pt_PT
oaire.citation.startPage2400089
oaire.citation.titleEurosurveillance: Europe's journal on infectious disease surveillance, epidemiology, prevention and control
oaire.citation.volume29pt_PT
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85
person.familyNameRodrigues
person.familyNameMachado
person.familyNameGuiomar
person.familyNameGOMEZ TEIXEIRA PINTO
person.givenNameAna Paula
person.givenNameAusenda
person.givenNameRaquel
person.givenNameVERÓNICA DEL PILAR
person.identifier.ciencia-id1217-6076-5D88
person.identifier.ciencia-idAE10-5FAB-7439
person.identifier.ciencia-idFA1B-D68F-2611
person.identifier.orcid0000-0003-2264-4723
person.identifier.orcid0000-0002-1849-1499
person.identifier.orcid0000-0002-4563-6315
person.identifier.orcid0000-0003-0485-0005
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublicationc23c6d96-e605-424f-abbb-64d783c73939
relation.isAuthorOfPublication544ad266-0c22-4a50-9ebc-86acc08d6666
relation.isAuthorOfPublication9743082d-bed6-4e5e-94f5-1d27bb037bb0
relation.isAuthorOfPublicationeae04cda-2c73-437b-8666-6593d03aa34d
relation.isAuthorOfPublication.latestForDiscovery9743082d-bed6-4e5e-94f5-1d27bb037bb0

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
eurosurv-29-8-1.pdf
Size:
653.99 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: